GLI1 and breast cancer: Indeed, the expression of GLI1, a key transcription factor in the downstream of Hh signaling, clinically associates with unfavorable prognosis of breast cancer patients [3], and experimentally the conditional expression of GLI1 in a transgenic mouse model induced mammary tumors [4], suggesting a crucial role of GLI1 in breast cancer development.